Esense-Lab logo

ESE - Esense-Lab Share Price

A$0.018 0.0  0.0%

Last Trade - 22/07/20

Sector
Healthcare
Size
Micro Cap
Market Cap £1.77m
Enterprise Value £1.44m
Revenue £9.93k
Position in Universe th / 1835
Bullish
Bearish
Unlock ESE Revenue
Momentum
Relative Strength (%)
1m -9.00%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -65.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.084 0.027 0.013
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Esense-Lab Ltd revenues decreased 52% to $13K. Net loss decreased 33% to $1.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Financial income increase from $0K to $257K (income), General and Administrative Expenses - decrease of 19% to $887K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ESE Revenue Unlock ESE Revenue

Net Income

ESE Net Income Unlock ESE Revenue

Normalised EPS

ESE Normalised EPS Unlock ESE Revenue

PE Ratio Range

ESE PE Ratio Range Unlock ESE Revenue

Dividend Yield Range

ESE Dividend Yield Range Unlock ESE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ESE EPS Forecasts Unlock ESE Revenue
Profile Summary

Esense-Lab Ltd is an Israel-based pharmaceutical technology company. The Company re-engineers cannabis into a virtual plant, namely terpene, a naturally occurring chemical compounds that generate the flavor and fragrance synthesized by plants. Tarpene can be used both for medicinal purposes and for the production of cannabis-based consumer products. The Company mainly serves the legal cannabis and para-cannabis markets. It also serves the: e-liquid market; pharmaceuticals market, creating on demand customized profiles and personalized medicine, as well as rare plants market, providing sustainability to rare and sought after plants such as ginseng and saffron. Its cannabis terpenes address the cannabis edibles, e-liquids and energy drinks, as well as the essential oils markets.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated April 13, 2016
Public Since February 14, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 180,139,414
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ESE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ESE
Upcoming Events for ESE
Frequently Asked Questions for Esense-Lab
What is the Esense-Lab share price?

As of 22/07/20, shares in Esense-Lab are trading at A$0.018, giving the company a market capitalisation of £1.77m. This share price information is delayed by 15 minutes.

How has the Esense-Lab share price performed this year?

Shares in Esense-Lab are currently trading at A$0.018 and the price has moved by -40% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Esense-Lab price has moved by -33.54% over the past year.

What are the analyst and broker recommendations for Esense-Lab?

There are no analysts currently covering Esense-Lab.

When will Esense-Lab next release its financial results?

Esense-Lab is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Esense-Lab dividend yield?

Esense-Lab does not currently pay a dividend.

Does Esense-Lab pay a dividend?

Esense-Lab does not currently pay a dividend.

When does Esense-Lab next pay dividends?

Esense-Lab does not currently pay a dividend.

How do I buy Esense-Lab shares?

To buy shares in Esense-Lab you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Esense-Lab?

Shares in Esense-Lab are currently trading at A$0.018, giving the company a market capitalisation of £1.77m.

Where are Esense-Lab shares listed? Where are Esense-Lab shares listed?

Here are the trading details for Esense-Lab:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: ESE
What kind of share is Esense-Lab?

We were not able to load our ranking data for Esense-Lab

Is there a Esense-Lab share price forecast 2020?

We were not able to load any forecast data for Esense-Lab.

How can I tell whether the Esense-Lab share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Esense-Lab. Over the past six months, the relative strength of its shares against the market has been 61.83%. At the current price of A$0.018, shares in Esense-Lab are trading at 17.59% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Esense-Lab PE Ratio?

We were not able to find PE ratio data for Esense-Lab.

Who are the key directors of Esense-Lab?

We were unable to find the directors for Esense-Lab.

Who are the major shareholders of Esense-Lab?

Here are the top five shareholders of Esense-Lab based on the size of their shareholding:

Chifley Portfolios Pty. Ltd. Corporation
Percentage owned: 6.27% (32.0m shares)
DRH Superannuation Pty. Ltd. Corporation
Percentage owned: 2.64% (5.00m shares)
Hannon (David) Individual Investor
Percentage owned: 2.45% (12.5m shares)
Ahmad (Bilal) Individual Investor
Percentage owned: 2.24% (4.25m shares)
Romfal Sifat Pty. Ltd. Corporation
Percentage owned: 1.33% (6.78m shares)
Similar to ESE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.